Popular Skinny Pills Linked to Digestive Problems
Research confirms skinny shots and pills are linked with gastrointestinal problems. They don't work long-term, but this strategy can change the fundamental issue.
STORY AT-A-GLANCE
A 2023 study in JAMA revealed glucagon-like peptide-1 (GLP-1) receptor agonist drugs prescribed for diabetes and weight loss increase your risk for pancreatitis, gastroparesis and bowel obstruction
These drugs include the two most popular GLP-1 receptor agonists semaglutide (Ozempic) and liraglutide (Saxenda and Victoza). They are part o…
